Variant report
Variant | esv2760584 |
---|---|
Chromosome Location | chr2:189564499-189584350 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs75930425 | chr2:189564505-189564506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs551141640 | chr2:189564579-189564580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs572660887 | chr2:189564606-189564607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs181914776 | chr2:189564682-189564683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10173369 | chr2:189564693-189564694 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs185889013 | chr2:189564729-189564730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs117046538 | chr2:189564748-189564749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs563671203 | chr2:189564854-189564855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs189954295 | chr2:189564879-189564880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs552792304 | chr2:189564880-189564881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571148143 | chr2:189564921-189564922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs377350800 | chr2:189564967-189564968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs182602487 | chr2:189564993-189564994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547191756 | chr2:189565016-189565017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs75556117 | chr2:189565042-189565043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs564572769 | chr2:189565062-189565063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs535501072 | chr2:189565118-189565119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs117336381 | chr2:189565149-189565150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs568791556 | chr2:189565170-189565171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs11678035 | chr2:189565202-189565203 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs565130096 | chr2:189565207-189565208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs7599978 | chr2:189565261-189565262 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs540165801 | chr2:189565266-189565267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs184985783 | chr2:189565298-189565299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs573774889 | chr2:189565302-189565303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs542261479 | chr2:189565306-189565307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs34919713 | chr2:189565313-189565314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs563986636 | chr2:189565327-189565328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs563639647 | chr2:189565349-189565350 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs151053711 | chr2:189565352-189565353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs546214757 | chr2:189565380-189565381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs2678360 | chr2:189565491-189565492 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs116284997 | chr2:189565510-189565511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs34539181 | chr2:189565528-189565529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs547335424 | chr2:189565587-189565588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs144572530 | chr2:189565684-189565685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs529470433 | chr2:189565714-189565715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs550613093 | chr2:189565748-189565749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs529601161 | chr2:189565928-189565929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs568849482 | chr2:189565933-189565934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs539568281 | chr2:189565988-189565989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs561816393 | chr2:189566036-189566037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs116102122 | chr2:189566118-189566119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533807434 | chr2:189566137-189566138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs527929384 | chr2:189566140-189566141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs2660921 | chr2:189566141-189566142 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs116789888 | chr2:189566194-189566195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs537632173 | chr2:189566272-189566273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs541007103 | chr2:189566386-189566387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs559115778 | chr2:189566463-189566464 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:189561200-189569400 | Weak transcription | NHDF-Ad | bronchial |
2 | chr2:189561800-189566400 | Weak transcription | NH-A | brain |
3 | chr2:189562400-189566800 | Weak transcription | Dnd41 | blood |
4 | chr2:189566400-189567000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr2:189566400-189567000 | Enhancers | NH-A | brain |
6 | chr2:189566600-189567200 | Enhancers | HUVEC | blood vessel |
7 | chr2:189566800-189567200 | Enhancers | Dnd41 | blood |
8 | chr2:189567000-189570200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
9 | chr2:189569400-189570400 | Enhancers | NHDF-Ad | bronchial |
10 | chr2:189570200-189570600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr2:189582600-189585200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr2:189583400-189585000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr2:189584000-189584200 | Enhancers | Adipose Nuclei | Adipose |
14 | chr2:189584000-189584200 | Enhancers | Fetal Stomach | stomach |